Evidence map›Paper›PMID 24232636›Full record

ArticlePediatric research2014

Gestational diabetes induces alterations in the function of neonatal endothelial colony-forming cells.

Emily K Blue, Robert DiGiuseppe, Ethel Derr-Yellin, Juan Carlos Acosta, S Louise Pay, Helmut Hanenberg, Megan M Schellinger, Sara K Quinney, Julie A Mund, Jamie Case and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Pediatric research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Endothelial progenitor cells in pregnancy-related diseases.Clinical science (London, England : 1979) · 2023
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Emily K Blue1] Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana [2] Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana.
Robert DiGiuseppeDepartment of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana.
Ethel Derr-Yellin1] Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana [2] Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana.
Juan Carlos AcostaDepartment of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana.
S Louise PayHerman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana.
Helmut Hanenberg1] Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana [2] Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana [3] Indiana University Simon Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana.
Megan M SchellingerDepartment of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, Indiana.
Sara K QuinneyDepartment of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, Indiana.
Julie A Mund1] Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana [2] Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana [3] Indiana University Simon Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana.
Jamie Case1] Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana [2] Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana [3] Indiana University Simon Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana.
Laura S Haneline1] Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana [2] Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana [3] Indiana University Simon Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana [4] Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana [5] Department of Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis, Indiana.
Indiana University – Purdue University Indianapolis · USIndiana University School of Medicine

Funding

Tumor Microenvironment and Metastasis ProgramP30CA082709 · NCI · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI AMBER L. MOSLEY · 1999 to 2026
$59.3M
Quality Assurance and Quality Control Project Management: Improving Submissions and Study Conduct in the Human Subjects Research Prior Approval ProcessUL1TR002529 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI MOE, SHARON M, WIEHE, SARAH ELIZABETH · 2018 to 2022
$27.2M
Indiana Clinical and Translational Sciences InstituteUL1TR001108 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI DENNE, SCOTT C., SHEKHAR, ANANTHA · 2013 to 2017
$23.3M
Project-005U54DK106846 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI Reuben Kapur, Karen Elizabeth Pollok · 2015 to 2026
$9.7M
Indiana University Comprehensive Training in Clinical PharmacologyT32GM008425 · NIGMS · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI Zeruesenay Desta, Michael Thomas Eadon · 1992 to 2026
$7.7M
Indiana PREGMEDU10HD063094 · NICHD · INDIANA UNIVERSITY INDIANAPOLIS · PI HAAS, DAVID M. · 2010 to 2014
$4.2M
Regulating hematopoietic stem cells and hematopoiesis for clinical efficacyP30DK090948 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI BROXMEYER, HAL E., SROUR, EDWARD F · 2010 to 2014
$3.7M
Fanconi Anemia stem cells allow molecular characterization of acute leukemiaR01CA138237 · NCI · INDIANA UNIVERSITY INDIANAPOLIS · PI BAGBY, GROVER CARLTON, CLAPP, DAVID W · 2008 to 2012
$1.9M
Genetic Therapy for Fanconi AnemiaR01CA155294 · NCI · INDIANA UNIVERSITY INDIANAPOLIS · PI CLAPP, DAVID W, HANENBERG, HELMUT · 2011 to 2015
$1.6M
Endothelial Progenitor and Vascular Dysfunction in Infants of Diabetic MothersR01HL094725 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI HANELINE, LAURA S · 2009 to 2012
$1.5M
NCATS NIH HHS UL1 TR001108NCI NIH HHS CA138237-01NCI NIH HHS CA155294-01NCI NIH HHS P30 CA082709NCI NIH HHS P30 CA82709NCI NIH HHS R01 CA138237NCI NIH HHS R01 CA155294NHLBI NIH HHS R01 HL094725NICHD NIH HHS U10 HD063094NICHD NIH HHS U10HD063094NIDDK NIH HHS P30 DK090948NIDDK NIH HHS P30DK090948NIDDK NIH HHS U54 DK106846NIGMS NIH HHS T32 GM008425
6 · The paper itself

Abstract

backgroundChildren born to mothers with gestational diabetes mellitus (GDM) experience increased risk of developing hypertension, type 2 diabetes mellitus, and obesity. Disrupted function of endothelial colony-forming cells (ECFCs) may contribute to this enhanced risk. The goal of this study was to determine whether cord blood ECFCs from GDM pregnancies exhibit altered functionality.

methodsECFCs isolated from the cord blood of control and GDM pregnancies were assessed for proliferation, senescence, and Matrigel network formation. The requirement for p38MAPK in hyperglycemia-induced senescence was determined using inhibition and overexpression studies.

resultsGDM-exposed ECFCs were more proliferative than control ECFCs. However, GDM-exposed ECFCs exhibited decreased network-forming ability in Matrigel. Aging of ECFCs by serial passaging led to increased senescence and reduced proliferation of GDM-exposed ECFCs. ECFCs from GDM pregnancies were resistant to hyperglycemia-induced senescence compared with those from controls. In response to hyperglycemia, control ECFCs activated p38MAPK, which was required for hyperglycemia-induced senescence. In contrast, GDM-exposed ECFCs showed no change in p38MAPK activation under equivalent conditions.

conclusionIntrauterine exposure of ECFCs to GDM induces unique phenotypic alterations. The resistance of GDM-exposed ECFCs to hyperglycemia-induced senescence and decreased p38MAPK activation suggest that these progenitor cells have undergone changes that induce tolerance to a hyperglycemic environment.

Indexed as

AdultCell ProliferationCellular SenescenceCollagenDiabetes, GestationalDrug CombinationsEndothelial CellsEnzyme ActivationFemaleFetal BloodHumansHyperglycemiaInfant, NewbornLamininMaleMaternal-Fetal ExchangeCollagenDrug CombinationsLamininmatrigelp38 Mitogen-Activated Protein KinasesProteoglycans

Identifiers

PMID24232636
PMCPMC3944713
OpenAlexW1978243978

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.